Practical hints for the diagnosis of mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system

被引:0
|
作者
Mattiolo, Paola [1 ,2 ,3 ]
机构
[1] Univ Verona, Dept Diagnost & Publ Hlth, Univ & Hosp Trust Verona, Sect Pathol, Piazzale LA Scuro 10, I-37134 Verona, Italy
[2] Heinrich Heine Univ, Dept Pathol, D-40225 Dusseldorf, Germany
[3] Univ Hosp Duesseldorf, D-40225 Dusseldorf, Germany
关键词
Mixed neuroendocrine-non-neuroendocrine neoplasm; Digestive system; Neuroendocrine neoplasm; Immunohistochemistry; CARCINOID-TUMORS; CLASSIFICATION; IMMUNOHISTOCHEMISTRY; PANCREAS;
D O I
10.4251/wjgo.v16.i11.4326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this editorial, a comment on the article by D & iacute;az-L & oacute;pez et al published in the recent issue of the 2024 is provided. We focus on the practical implications critical for providing a correct and complete diagnosis of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) in the gastrointestinal system. The diagnosis of MiNEN begins with the recognition of neuroendocrine features in one component of a biphasic tumor. The non-neuroendocrine counterpart can be virtually represented by any neoplastic type, even though the most frequent histologies are glandular and squamous. However, qualification of the neuroendocrine component requires histological and immunohistochemical confirmation. Neuroendocrine tumors are characterized by a peculiar architectural organization and bland nuclei with granular "salt and pepper" chromatin. Although neuroendocrine carcinomas have multiple and variable presentations, they typically show a solid or organoid architecture. The histological aspect needs to be confirmed by immunohistochemistry, and a diagnosis is confirmed whenever the expression of keratin and neuroendocrine markers is observed. Once both histopathological and immunohistochemical features of neuroendocrine neoplasms are identified, it is important to consider the three major pitfalls of MiNEN diagnostics: (1) Entrapment of neuroendocrine non-neoplastic cells within the tumor mass; (2) Differential diagnosis with amphicrine neoplasms; and (3) Differential diagnosis of tumors that partially express neuroendocrine markers. According to the current guidelines for diagnosing digestive MiNEN, each component must represent at least 30% of the entire neoplastic mass. Although the high-grade histopathological subtype frequently determines disease prognosis, both components can significantly affect prognosis. Thus, if one of the components, either neuroendocrine or non-neuroendocrine, does not fulfill the volumetric criteria, the guidelines still encourage reporting it. These strict criteria are essential for correctly recognizing and characterizing digestive MiNENs. This task is essential because it has prognostic relevance and substantial potential value for guiding further studies in this field. In the future, systematic analyses should be performed to validate or reconsider the current 30% cutoff value.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Ulcerative Colitis Associated with a Mixed Neuroendocrine-non-neuroendocrine Neoplasm
    Kinugasa, Hideaki
    Hiraoka, Sakiko
    Oka, Shohei
    Okada, Hiroyuki
    INTERNAL MEDICINE, 2020, 59 (16) : 2085 - 2086
  • [32] Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report
    Skalicky, Adam
    Vistejnova, Lucie
    Dubova, Magdalena
    Malkus, Tomas
    Skalicky, Tomas
    Troup, Ondrej
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [33] Surgical resection of mixed neuroendocrine-non-neuroendocrine neoplasm in the biliary system: a report of two cases
    Ayano Tamaki
    Yuma Tani
    Hiroki Sato
    Ryuichi Yoshida
    Kazuya Yasui
    Shigeru Horiguchi
    Takashi Kuise
    Yuzo Umeda
    Kazuhiro Yoshida
    Tomokazu Fuji
    Kenjiro Kumano
    Kosei Takagi
    Takahito Yagi
    Toshiyoshi Fujiwara
    Surgical Case Reports, 8
  • [34] Gene expression profiling of pancreatic neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm
    Kinowaki, Yuko
    Fukumura, Yuki
    Kawade, Genji
    Sugita, Keisuke
    Kinowaki, Keiichi
    Akahoshi, Keiichi
    Kobayashi, Masanori
    Ono, Hiroaki
    Kudo, Atsushi
    Tanabe, Minoru
    Akashi, Takumi
    Ohashi, Kenichi
    Kurata, Morito
    GENE, 2024, 893
  • [35] Mixed neuroendocrine-non-neuroendocrine neoplasm of the ampulla of Vater: a case report
    Saguem, I.
    Manai, M.
    Mellouli, M.
    Ben Tekaya, S.
    Graja, S.
    Trigui, A.
    Boudawara, T.
    Kallel, R.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S228 - S228
  • [36] Adjuvant therapy for mixed neuroendocrine-non-neuroendocrine neoplasm of the ampulla of Vater
    Wang, Xinghong
    Sun, Feng
    Wang, Shengjin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3163 - 3164
  • [37] Mixed neuroendocrine-non-neuroendocrine neoplasm of the ampulla of Vater: a case report
    Date, Kenjiro
    Tatsuguchi, Takaaki
    Shimokawa, Yuzo
    Niina, Yusuke
    Kitahara, Daichi
    Kuga, Hirotaka
    Tamiya, Sadafumi
    Nishihara, Kazuyoshi
    Nakano, Toru
    SURGICAL CASE REPORTS, 2023, 9 (01)
  • [38] Recurrent Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm in the Gallbladder: A Case Report
    Al-Fayea, Turki
    Alzahrani, Mohammed
    Almaghrabi, Hatim
    Alghamdi, Abdulrahman
    Mohammed, Kabo
    CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 411 - 417
  • [39] Surgical resection of mixed neuroendocrine-non-neuroendocrine neoplasm in the biliary system: a report of two cases
    Tamaki, Ayano
    Tani, Yuma
    Sato, Hiroki
    Yoshida, Ryuichi
    Yasui, Kazuya
    Horiguchi, Shigeru
    Kuise, Takashi
    Umeda, Yuzo
    Yoshida, Kazuhiro
    Fuji, Tomokazu
    Kumano, Kenjiro
    Takagi, Kosei
    Yagi, Takahito
    Fujiwara, Toshiyoshi
    SURGICAL CASE REPORTS, 2022, 8 (01)
  • [40] Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
    Holmager, Pernille
    Langer, Seppo W.
    Kjaer, Andreas
    Ringholm, Lene
    Garbyal, Rajendra Singh
    Pommergaard, Hans-Christian
    Hansen, Carsten Falnaes
    Federspiel, Birgitte
    Andreassen, Mikkel
    Knigge, Ulrich
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (06) : 806 - 817